Further investigation of the modifying effect of various chemopreventive agents on apoptosis and cell proliferation in human colon cancer cells

Journal of Cancer Research and Clinical Oncology

Volumn 128, Issue 10, 2002, Pages 539-546

  Zheng, Qiao ^a   Hirose, Yoshinobu ^a   Yoshimi, Naoki ^b   Murakami, Akira ^d   Koshimizu, Koichi ^c   Ohigashi, Hajime ^d   Sakata, Keiko ^a   Matsumoto, Yuji ^e   Sayama, Yoshikatsu ^e   Mori, Hideki ^a  

^a GIFU UNIVERSITY   (Japan)

^b UNIVERSITY OF THE RYUKYUS   (Japan)

^c KINKI UNIVERSITY   (Japan)

^d KYOTO UNIVERSITY   (Japan)

^e Product Research and Development Dept   (Japan)

Author keywords

Apoptosis; Cell proliferation; Chemopreventive agents; Colon cancer

Indexed keywords

1' ACETOXYCHAVICOL ACETATE; 2,5 DI O ACETYL DEXTRO 1,4 GLUCARO 6,3 DILACTONE; 3 (4,5 DIMETHYLTHIAZOL 2 YL) 5 (3 CARBOXYMETHOXYPHENYL) 2 (4 SULFOPHENYL) 2H TETRAZOLIUM; 3 INDOLEMETHANOL; 4 DIAMIDINO 2 PHENYLINDOLE; ACETIC ACID DERIVATIVE; ANTINEOPLASTIC AGENT; AURAPTENE; BROXURIDINE; CHLOROGENIC ACID; DEXTRO GLUCURONIC ACID GAMMA LACTONE; DIOSMIN; DNA; DNA FRAGMENT; HESPERIDIN; INDOLE DERIVATIVE; LACTONE DERIVATIVE; NOBILETIN; PROTOCATECHUIC ACID; SINIGRIN; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER PREVENTION; CELL LABELING; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; CHEMOPROPHYLAXIS; COLORECTAL CANCER; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA REPLICATION; DNA SYNTHESIS INHIBITION; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; ENZYME IMMUNOASSAY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STAINING; TIME;

ANTICARCINOGENIC AGENTS; APOPTOSIS; BROMODEOXYURIDINE; CELL DIVISION; CHEMOPREVENTION; COLORECTAL NEOPLASMS; DNA; HUMANS; TUMOR CELLS, CULTURED;

EID: 0036035557     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-002-0373-y     Document Type: Article

References (42)

1. Bertagnolli MM, McDougall CJ, Newmark HL (1997) Colon cancer prevention: Intervening in a multistage process. Proc Soc Exp Biol Med 216:266-274
2. Boone CW, Kelloff GJ, Malone WE (1990) Identification of candidate cancer chemopreventive agents and their evaluation in animal models and human clinical trials: A review. Cancer Res 50:2-9
3. Cory AH, Owen C, Barltrop JA, Cory JG (1991) Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays in cultures. Cancer Commun 3:207-212
4. Cuendet M, Pezzuto JM (2000) The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol Drug Interact 17:109-157
5. Hagedorn M, Bikfalvi A (2000) Target molecules for anti-angiogenic therapy: From basic research to clinical trials. Crit Rev Oncol Hematol 34:89-110
6. Hara A, Yoshimi N, Niwa M, Ino N, Mori H (1997) Apoptosis induced by NS-398, a selective cyclooxygenase-2 inhibitor, in human colorectal cancer cell lines. Jpn J Cancer Res 88:600-604
7. Hursting SD, Slaga TJ, Fischer SM (1999) Mechanism-based cancer prevention approaches: Targets, examples, and the use of transgenic mice. J Natl Cancer Inst 91:215-225
8. Jacoby RF, Cole CE, Tutsch K, Newton MA, Kelloff G, Hawk ET, Lubet RA (2000) Chemopreventive efficacy of combined piroxicam and difluoromethylornithine treatment of Apc mutant Min mouse adenomas, and selective toxicity against Apc mutant embryos. Cancer Res 60:1864-1870
9. Kelloff GJ, Boone CW, Steele VE, Fay JR, Lubet RA, Crowell JA, Sigman CC (1994) Mechanistic considerations in chemopreventive drug development. J Cell Biochem Suppl 20:1-24
10. Kitts DD, Wijewickreme AN (1994) Effect of dietary caffeic and chlorogenic acids on in vivo xenobiotic enzyme systems. Plant Foods Hum Nutr 45:287-298
11. Kralj M, Kapitanovic S, Kovacevic, D, Lukac J, Spaventi S, Pavelic K (2001) Effect of the nonsteroidal anti-inflammatory drug indomethacin on proliferation and apoptosis of colon carcinoma cells. J Cancer Res Clin Oncol 127:173-179
12. Lee WR, Shen SC, Lin HY, Hou WC, Yang LL, Chen YC (2002) Wogonin and fisetin induce apoptosis in human promyeloleukemic cells, accompanied by a decrease of reactive oxygen species, and activation of caspase 3 and Ca(2+)-dependent endonuclease. Biochem Pharmacol 63:225-236
13. Livingston DM, Shivdasani R (2001) Toward mechanism-based cancer care. JAMA 285:588-593
14. Manson MM, Ball HW, Barrett MC, Clark HL, Judah DJ, Williamson G, Neal GE (1997) Mechanism of action of dietary chemopreventive agents in rat liver: Induction of phase I and phase II drug metabolizing enzymes and aflatoxin B1 metabolism. Carcinogenesis 18:1729-1738
15. Mori H, Tanaka T, Shima H, Kuniyasu T, Takahashi M (1986) Inhibitory effect of chlorogenic acid on methylazoxymethanol acetate-induced carcinogenesis in large intestine and liver of hamsters. Cancer Lett 30:49-54
16. Mori H, Sugie S, Yoshimi N, Hara A, Tanaka T (1999) Control of cell proliferation in cancer prevention. Mutat Res 428:291-298
17. Mori H, Niwa K, Zheng Q, Yamada Y, Sakata K, Yoshimi N (2001) Cell proliferation in cancer prevention; effects of preventive agents on estrogen-related endometrial carcinogenesis model and on an in vitro model in human colorectal cells. Mutat Res 480:201-207
18. Murakami A, Nakamura Y, Ohto Y, Yano M, Koshiba T, Koshimizu K, Tokuda H, Nishino H, Ohigashi H (2000a) Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid. Biofactors 12:187-192
19. Murakami A, Nakamura Y, Tanaka T, Kawabata K, Takahashi D, Koshimizu K, Ohigashi H (2000b) Suppression by citrus auraptene of phorbol ester- and endotoxin-induced inflammatory responses: Role of attenuation of leukocyte activation. Carcinogenesis 21:1843-1850
20. Murakami A, Nakamura Y, Torikai K, Tanaka T, Koshiba T, Koshimizu K, Kuwahara S, Takahashi Y, Ogawa K, Yano M, Tokuda H, Nishino H, Mimaki Y, Sashida Y, Kitanaka S, Ohigashi H (2000c) Inhibitory effect of citrus nobiletin on phorbol ester-induced skin inflammation, oxidative stress, and tumor promotion in mice. Cancer Res 60:5059-5066
21. Nishikawa M, Takeda K, Sato EF, Kuroki T, Inoue M (1997) Nitric oxide regulates energy metabolism and Bcl-2 expression in intestinal epithelial cells. Am J Physiol 274:797-801
22. Ohata T, Fukuda K, Murakami A, Ohigashi H, Sugimura T, Wakabayashi K (1998) Inhibition by 1'-acetoxychavicol acetate of lipopolysaccharide- and interferon-gamma-induced nitric oxide production through suppression of inducible nitric oxide synthase gene expression in RAW264 cells. Carcinogenesis 19:1007-1012
23. Pasricha PJ, Bedi A, O'Connor K, Rashid A, Akhtar AJ, Zahurak ML (1995) The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis. Gastroenterology 109:994-998
24. Rao CV, Tokumo K, Rigotty J, Zang E, Kelloff G, Reddy BS (1991) Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, alpha-difluoromethylornithine, 16 alpha-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res 51:4528-4534
25. Reddy BS (2000) The Fourth DeWitt S. Goodman lecture. Novel approaches to the prevention of colon cancer by nutritional manipulation and chemoprevention. Cancer Epidemiol Biomarkers Prev 9:239-247
26. Samaha HS, Kelloff GJ, Steele V, Rao CV, Reddy BS (1997) Modulation of apoptosis by sulindac, curcumin, phenylethyl-3-methylcaffeate, and 6-phenylhexyl isothiocyanate: Apoptotic index as a biomarker in colon cancer chemoprevention and promotion. Cancer Res 57:1301-1305
27. Sheng H, Shao J, Morrow JD, Beauchamp RD, Dubois RN (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58:362-366
28. Sim BK, MacDonald NJ, Gubish, ER (2000) Angiostatin and endostatin: Endogenous inhibitors of tumor growth. Cancer Metastasis 19:181-190
29. Tanaka T, Mori Y, Morishita Y, Hara A, Ohno T, Kojima T, Mori H (1990) Inhibitory effect of sinigrin and indole-3-carbinol on diethylnitrosamine-induced hepatocarcinogenesis in male ACI/N rats. Carcinogenesis 11:1403-1406
30. Tanaka T, Kojima T, Morishita Y, Mori H (1992) Effect of naturally occurring products, indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis. Jpn J Cancer Res 83:835-842
31. Tanaka T, Kojima T, Suzui M, Mori H (1993) Chemoprevention of colon carcinogenesis by the natural product of a simple phenolic compound protocatechuic acid: Suppressing effects on tumor development and biomarkers expression of colon tumorigenesis. Cancer Res 53:3908-3913
32. Tanaka T, Kawabata K, Kakumoto M, Makita H, Matsunaga K, Mori H, Satoh K, Hara A, Murakami A, Koshimizu K, Ohigashi H (1997a) Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate. Jpn J Cancer Res 88:821-830
33. Tanaka T, Makita H, Kawabata K, Mori H, Kakumoto M, Satoh K, Hara A, Sumida T, Tanaka T, Ogawa H (1997b) Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis 18:957-965
34. Tanaka T, Kawabata K, Kakumoto M, Hara A, Murakami A, Kuki W, Takahashi Y, Yonei H, Maeda M, Ota T, Odashima S, Yamane T, Koshimizu K, Ohigashi H (1998) Citrus auraptene exerts dose-dependent chemopreventive activity in rat large bowel tumorigenesis: The inhibition correlates with suppression of cell proliferation and lipid peroxidation and with induction of phase II drug-metabolizing enzymes. Cancer Res 58:2550-2556
35. Tosetti F, Ferrari N, De Flora S, Albini A (2002) Angioprevention: Angiogenesis is a common and key target for cancer chemopreventive agents. FASEB J 16:2-14
36. Waddell WR (1998) Stimulation of apoptosis by sulindac and piroxicam. Clin Sci (Colch) 95:385-388
37. Walaszek Z, Hanausek-Walaszek M, Webb TE (1984) Inhibition of 7,12-dimethylbenzanthracene-induced rat mammary tumorigenesis by 2,5-di-O-acetyl-D-glucaro-1,4: 6,3-Dilactone, an In vivo β-glucuronidase inhibitor. Carcinogenesis 5:767-772
38. Walaszek Z, Hanausek-Walaszek M, Minton JP, Webb TE (1986) Dietary glucarate as anti-promoter of 7,12-dimethylbenzaanthracene-induced mamary tumorigenesis. Carcinogenesis 7:1463-1466
39. Walaszek Z, Szemraj J, Narog M, Adams AK, Kilgore J, Sherman U, Hanausek M (1997) Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention. Cancer Detect Prev 21:178-190
40. Watson AJ (1998) Chemopreventive effects of NSAIDs against colorectal cancer: Regulation of apoptosis and mitosis by COX-1 and COX-2. Histol Histopathol 13:591-597
41. Wattenberg LW (1985) Chemoprevention of cancer. Cancer Res 45:1-8
42. Williamson G, Faulkner K, Plumb GW (1998) Glucosinolates and phonolics as antioxidants from plant foods. Eur J Cancer Prev 7:17-21